Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Cancer Research
Published in: Chinese Journal of Cancer Research 4/2012

01-12-2012 | Case Report

Evaluation of treatment response for breast cancer: are we entering the era of “biological complete remission”?

Authors: Li Bian, Tao Wang, Yi Liu, Hui-Qiang Zhang, Jin-Jie Song, Shao-Hua Zhang, Shi-Kai Wu, San-Tai Song, Ze-Fei Jiang

Published in: Chinese Journal of Cancer Research | Issue 4/2012

Login to get access
Metadata
Title
Evaluation of treatment response for breast cancer: are we entering the era of “biological complete remission”?
Authors
Li Bian
Tao Wang
Yi Liu
Hui-Qiang Zhang
Jin-Jie Song
Shao-Hua Zhang
Shi-Kai Wu
San-Tai Song
Ze-Fei Jiang
Publication date
01-12-2012
Publisher
Chinese Anti-Cancer Association
Published in
Chinese Journal of Cancer Research / Issue 4/2012
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI
https://doi.org/10.1007/s11670-012-0281-x

Other articles of this Issue 4/2012

Chinese Journal of Cancer Research 4/2012 Go to the issue

Original Article

High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy

Original Article

The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer

Editorial

Expression of Gli1 in the hedgehog signaling pathway and breast cancer recurrence

Review Article

Potential effects of CRM1 inhibition in mantle cell lymphoma

Original Article

Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling

Original Article

Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits